Skip to content

Effect of continuous noninvasive blood pressure monitoring (T-LINE 300) for elderly patients on perioperative precise management and prognosis: a randomized controlled trial

Effect of continuous noninvasive blood pressure monitoring (T-LINE 300) for elderly patients on perioperative precise management and prognosis: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900023072
Enrollment
Unknown
Registered
2019-05-10
Start date
2019-06-01
Completion date
Unknown
Last updated
2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical Patients

Interventions

T-LINE group:noninvasive continuous blood pressure monitoring by T-LINE 300
NIBP group:traditional intermittent blood pressure monitoring

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged = 65 years. 2. Elective surgery. 3. Agree to participate in this clinic trail and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Could not receive noninvasive continuous blood pressure monitoring and traditional cuff blood pressure monitoring simultaneously. 2. Patient not suitable for continuous noninvasive blood pressure monitoring: 1) Monitoring side has no evident radial artery pulse; 2) Monitor could not be applied to anatomy abnormal or injured parts (skin graft, abscess, cellulitis, scar, wound, burn, bruise or scratch); 3) vein locates at the sensor range; 4) Electrotome negative plate locates on the monitoring arm; 5) upper limb surgery. 3. Anesthesiologist decides the patient must receive invasive blood pressure monitoring, controlled hypotension or repeated ABG monitoring. 4. Any reason for the patient could not cooperate with the study (such as language barrier, mental illness or could not come to the hospital for follow-up); 5. Participated in other clinical trials or took investigational drugs within 3 months before enrollment.

Design outcomes

Primary

MeasureTime frame
Composite complication;

Secondary

MeasureTime frame
Intraoperative, 7 days and 30 days postoperative occurrence of severe complications;Intraoperative, 7 days and 30 days postoperative occurrence of mild to moderate complications;Total cost for hospitalization;Total cost of ICU stay;Cost from surgery to discharge;Length of stay and ICU length of stay;Rate of transferring to ICU;Times and duration of MBP 100 mmHg.;Times and duration of SBP = 140 mmHg, SBP > surpass 20% of baseline and SBP surpass 30% of baseline and SBP 90 mmHg.;Rate of conversion to invasive blood pressure monitoring intraoperatively.;

Countries

China

Contacts

Public ContactChen Guo

West China Hospital, Sichuan University

894397461@qq.com+86 18980601577

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026